Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education to Reduce Emergency Department Visits, Re-admissions and Adverse Cardiovascular Outcomes in Hypertensive Disorder of Pregnancy

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if patient education and regular text reminders are a feasible intervention to engage patients and reduce post partum hypertension. The main questions it aims to answer are: Is a structured postpartum remote blood pressure monitoring intervention with education and individualized medication initiation/adjustment follow-up by televisit feasible? Does a structured program reduce the occurrence of postpartum hypertension, ED visits, hospital readmissions, and adverse outcomes? Participants will: View an educational video on HDP post-delivery Receive 1-2 times daily text messages for 6 weeks postpartum Have their blood pressure medications adjusted to lower targets post partum

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Age of at least 18 years.

• Postpartum status.

• Experience new-onset hypertension during pregnancy.

• Enrollment in Connected MOM.

• Ability to provide informed consent.

• Establish medical care within the Ochsner System to facilitate data collection.

Locations
United States
Louisiana
Ochsner Baptist
RECRUITING
New Orleans
Contact Information
Primary
Salima Qamruddin, MD
salima.qamruddin@ochsner.org
+1 (504) 842-4135
Time Frame
Start Date: 2025-03-17
Estimated Completion Date: 2026-10-16
Participants
Target number of participants: 296
Treatments
Experimental: Intervention
This group will watch an education video, receive text message updates, and have their blood pressure medications titrated to a lower BP goal.
No_intervention: Control
This group will receive usual post partum care from their obstetrician
Related Therapeutic Areas
Sponsors
Leads: Ochsner Health System

This content was sourced from clinicaltrials.gov